Liang Zhao

US Patent:

20130024929, Jan 24, 2013

Filed:

Jul 20, 2011

Appl. No.:

13/186474

Inventors:

SAJI ABRAHAM - Kirkland WA, US
Hart Wilson - Auburn WA, US
Tassaduq Basu - Redmond WA, US
Sermet Iskin - Bellevue WA, US
Liang Zhao - Bothell WA, US

Assignee:

Microsoft Corporation - Redmond WA

International Classification:

G06F 21/00

US Classification:

726 16

Abstract:

An isolation execution environment provides an application with limited resources to execute an application. The application may require access to secured resources associated with a particular trust level that are outside of the isolation execution environment. A trust activation engine determines the trust level associated with a request for a resource and operates differently based on the trust level. A broker process may be used to execute components providing access to resources having a partial trust level in an execution environment that is separate from the isolation execution environment.

US Patent:

20130061316, Mar 7, 2013

Filed:

Sep 6, 2011

Appl. No.:

13/225945

Inventors:

Sermet Iskin - Bellevue WA, US
John A.M. Hazen - Kirkland WA, US
Liang Zhao - Bothell WA, US
Scott B. Graham - Seattle WA, US
John M. Sheelan - Cambridge MA, US

Assignee:

Microsoft Corporation - Redmond WA

International Classification:

G06F 21/00

US Classification:

726 18

Abstract:

Capability access management techniques for processes are described. In one or more implementations, a token is formed having one or more security identifiers that reference capabilities described in a manifest for the executable code responsive to an input received to initiate execution of executable code installed on the computing device. The one or more processes formed through execution of the executable code on the computing device are associated with the token, the token usable to manage access of the one or more processes to the capabilities of the computing device.

US Patent:

20150106915, Apr 16, 2015

Filed:

Nov 30, 2014

Appl. No.:

14/556221

Inventors:

- REDMOND WA, US
HART WILSON - AUBURN WA, US
TASSADUQ BASU - REDMOND WA, US
SERMET ISKIN - BELLEVUE WA, US
LIANG ZHAO - BOTHELL WA, US

International Classification:

G06F 21/60

US Classification:

726 16

Abstract:

An isolation execution environment provides an application with limited resources to execute an application. The application may require access to secured resources associated with a particular trust level that are outside of the isolation execution environment. A trust activation engine determines the trust level associated with a request for a resource and operates differently based on the trust level. A broker process may be used to execute components providing access to resources having a partial trust level in an execution environment that is separate from the isolation execution environment.

US Patent:

20150073011, Mar 12, 2015

Filed:

Apr 2, 2013

Appl. No.:

14/389854

Inventors:

- Sodertalje, SE
Shanta Bist - Waltham MA, US
Neil Bifulco - Waltham MA, US
Liang Zhao - Waltham MA, US
Ye Wu - Waltham MA, US
Hoan Huynh - Waltham MA, US
Hui Xiong - Waltham MA, US
Janelle Comita-Prevoir - Waltham MA, US
Daemian Dussault - Waltham MA, US
Bolin Geng - Waltham MA, US
Brendan Chen - Waltham MA, US
Thomas Durand-Reville - Waltham MA, US
Satenig Guler - Waltham MA, US

Assignee:

ASTRAZENECA AB - Sodertalje

International Classification:

C07D 471/08

US Classification:

514300, 546121

Abstract:

The present invention is directed to compounds which are beta-lacatamase inhibitors. The compounds and their pharmaceutically acceptable salts, are useful in combination with beta-lactam antibiotics, or alone, for the treatment of bacterial infections, including infections caused by drug resistant organisms, including multi-drug resistant organisms. The present invention includes compounds according to formula (Ia):or a pharmaceutically acceptable salt thereof, wherein the values of R, R, Rand Rare described herein.